Literature DB >> 24975752

Subjective depressive symptoms and metabolic syndrome among the general population.

Sang Jin Rhee1, Eun Young Kim1, Se Hyun Kim2, Hyun Jeong Lee1, Bora Kim1, Kyooseob Ha3, Dae Hyun Yoon4, Yong Min Ahn5.   

Abstract

OBJECTIVE: The evidence of the association between depression and metabolic syndrome is increasing, but the existence of sex differences in this association remains controversial. The aim of this study was to investigate the association between subjective depressive symptoms and metabolic syndrome and each of its components by sex in the Korean population.
METHODS: The study sample comprised 15,073 men and 15,034 women who underwent routine health examinations. They completed the Beck Depression Inventory for depressive symptoms, and medical examinations provided data regarding metabolic syndrome. Adjustments for age, marriage, cigarette smoking, alcohol use, exercise, education, cancer, stroke, angina, and thyroid disease were performed. The association between depressive symptoms and metabolic syndrome and each of its components was analyzed by multiple logistic regression.
RESULTS: In women, depressive symptoms were associated with metabolic syndrome (OR=1.35, 95% CI=1.11-1.64, p=0.002) and the high-density lipoprotein cholesterol component (OR=1.26, 95% CI=1.09-1.46, p=0.002) of metabolic syndrome. There was also an association between the severity of depressive symptoms and metabolic syndrome in women (OR=1.046, 95% CI=1.002-1.091, p=0.039). In men, depressive symptoms were inversely associated with the hypertension component of metabolic syndrome (OR=0.73, 95% CI=0.58-0.91, p=0.005).
CONCLUSIONS: Subjective depressive symptoms were associated with metabolic syndrome only in women. Further research should consider sex differences and dyslipidemia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Depressive symptoms; Gender; Lipid; Metabolic syndrome

Mesh:

Substances:

Year:  2014        PMID: 24975752     DOI: 10.1016/j.pnpbp.2014.06.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  15 in total

1.  Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.

Authors:  Emmanuelle Corruble; Khalil El Asmar; Severine Trabado; Céline Verstuyft; Bruno Falissard; Romain Colle; Anne-Cécile Petit; Florence Gressier; Sylvie Brailly-Tabard; Florian Ferreri; Jean-Pierre Lépine; Emmanuel Haffen; Mircea Polosan; Céline Bourrier; Gabriel Perlemuter; Philippe Chanson; Bruno Fève; Laurent Becquemont
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Depressive Symptoms, Antidepressant Use, and Hypertension in Young Adulthood.

Authors:  Danielle M Crookes; Ryan T Demmer; Katherine M Keyes; Karestan C Koenen; Shakira F Suglia
Journal:  Epidemiology       Date:  2018-07       Impact factor: 4.822

3.  Pioglitazone could induce remission in major depression: a meta-analysis.

Authors:  Romain Colle; Delphine de Larminat; Samuel Rotenberg; Franz Hozer; Patrick Hardy; Céline Verstuyft; Bruno Fève; Emmanuelle Corruble
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-19       Impact factor: 2.570

4.  Metabolic syndrome and depressive symptoms among rural Northeast general population in China.

Authors:  Shasha Yu; Hongmei Yang; Xiaofan Guo; Liqiang Zheng; Yingxian Sun
Journal:  BMC Public Health       Date:  2017-01-06       Impact factor: 3.295

5.  Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis.

Authors:  K L Ong; M J Morris; R L McClelland; J Maniam; M A Allison; K-A Rye
Journal:  Transl Psychiatry       Date:  2016-11-29       Impact factor: 6.222

6.  Anxiety but not depression is associated with metabolic syndrome: The Isfahan Healthy Heart Program.

Authors:  Hamed Akbari; Nizal Sarrafzadegan; Hamid Aria; Alireza Gholami Garaei; Habib Zakeri
Journal:  J Res Med Sci       Date:  2017-07-28       Impact factor: 1.852

Review 7.  Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review.

Authors:  Carla Gramaglia; Eleonora Gambaro; Giuseppe Bartolomei; Paolo Camera; Maira Chiarelli-Serra; Luca Lorenzini; Patrizia Zeppegno
Journal:  Front Psychiatry       Date:  2018-11-28       Impact factor: 4.157

8.  Psychiatric symptoms and related dysfunction in a general population sample.

Authors:  Lauren Smith; Abraham Reichenberg; Jonathan Rabinowitz; Stephen Z Levine; Eva Velthorst
Journal:  Schizophr Res Cogn       Date:  2018-08-11

9.  The association between family impact and health-related quality of life of children with idiopathic central precocious puberty in Chongqing, China.

Authors:  Hong Yang; Shunqing Luo; Xiaohua Liang; Qin Lin; Ting Cheng; Li Zeng; Fang Tang; Di Wu
Journal:  Health Qual Life Outcomes       Date:  2021-06-26       Impact factor: 3.186

10.  Symptoms of depression in young adulthood is associated with unfavorable clinical- and behavioral cardiovascular disease risk factors.

Authors:  Heidi Klakk; Peter Lund Kristensen; Lars Bo Andersen; Karsten Froberg; Niels Christian Møller; Anders Grøntved
Journal:  Prev Med Rep       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.